ORM-15341
98%
- Product Code: 62119
CAS:
1297537-33-7
| Molecular Weight: | 396.83 g./mol | Molecular Formula: | C₁₉H₁₇ClN₆O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
ORM-15341 is primarily investigated for its potential therapeutic applications in the field of oncology. It is being studied as a selective androgen receptor degrader (SARD), which targets and degrades androgen receptors in cancer cells. This mechanism is particularly relevant in the treatment of prostate cancer, where androgen receptors play a critical role in tumor growth and progression. By degrading these receptors, ORM-15341 aims to inhibit the proliferation of cancer cells and potentially slow down or halt the disease's advancement. Research is ongoing to evaluate its efficacy, safety, and potential as a novel treatment option for patients with advanced or resistant forms of prostate cancer.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Off-white Solid |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $243.02 |
+
-
|
| 0.010 | 10-20 days | $405.04 |
+
-
|
| 0.050 | 10-20 days | $1,215.12 |
+
-
|
ORM-15341
ORM-15341 is primarily investigated for its potential therapeutic applications in the field of oncology. It is being studied as a selective androgen receptor degrader (SARD), which targets and degrades androgen receptors in cancer cells. This mechanism is particularly relevant in the treatment of prostate cancer, where androgen receptors play a critical role in tumor growth and progression. By degrading these receptors, ORM-15341 aims to inhibit the proliferation of cancer cells and potentially slow down or halt the disease's advancement. Research is ongoing to evaluate its efficacy, safety, and potential as a novel treatment option for patients with advanced or resistant forms of prostate cancer.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :